National Congenital Heart Disease Audit
1 other identifier
observational
120,000
1 country
10
Brief Summary
The National Institute of Cardiovascular Outcomes Research (NICOR) collects data and produces analysis to enable hospitals and healthcare improvement bodies to monitor and improve the quality of care and outcomes of cardiovascular patients. The Congenital Heart Disease audit collects data on all cardiac surgery and therapeutic cardiac catheterisations procedures used to treat patients with congenital and acquired heart disease. For acquired heart disease, the audit covers all arrhythmias \& cardiomyopathies in patients less than 16 years old only. For congenital heart disease, the audit collects data on both children and adult patients. The audit covers all specialist centers in the UK and Republic of Ireland. The project aims to improve the quality of care for children and adults with congenital heart disease by providing national comparative analysis of procedure specific activity and outcomes of cardiac surgery and therapeutic cardiac catheterisation procedures. The audit also provides quality indicators for the antenatal detection of major congenital heart disease. The current dataset is available from here: http://www.ucl.ac.uk/nicor/audits/congenital/datasets
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2000
Longer than P75 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2000
CompletedFirst Submitted
Initial submission to the registry
November 25, 2014
CompletedFirst Posted
Study publicly available on registry
December 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedNovember 4, 2016
October 1, 2016
16.9 years
November 25, 2014
November 3, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
30 day survival rates
The analysis shows the national survival rates at 30 days for each procedure and the national survival rates for individual procedures by age.
30 day survival from operation date
Secondary Outcomes (1)
1 year survival rates
1 year survival rates after the date of the procedure
Study Arms (1)
Congenital
All patients with congential and acquired heart disease treated by cardiac surgery and therapeutic cardiac catheterisations procedures . For acquired heart disease, the audit covers all arrhythmias \& cardiomyopathies in patients less than 16 years old only. For congenital heart disease, the audit collects data on both children and adult patients.
Interventions
All patients with congential and acquired heart disease treated by cardiac surgery procedures.
All patients with congential and acquired heart disease treated by therapeutic cardiac catheterisations procedures .
Eligibility Criteria
All potential patients are assessed through a systematic process of clinical evaluation, diagnostic assessment. Patient selection is effected in each individual unit through a multidisciplinary team process. These teams consist not only of cardiac surgeons and interventional cardiologists but also of many other medical specialties and allied professionals. The decision as to the access route to be used is determined by the multidisciplinary team.
You may qualify if:
- Patient, judged by multidisciplinary team meeting as unsuitable for the procedure
You may not qualify if:
- Patient, judged by multidisciplinary team meeting, as unsuitable for the procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Southampton General Hospital
Southampton, Hampshire, SO16 6YD, United Kingdom
Royal Brompton Hospital
London, London, SW3 6NP, United Kingdom
The Harley Street Clinic
London, London, W1G 8BJ, United Kingdom
Alder Hey Hospital
Liverpool, Merseyside, L12 2AP, United Kingdom
Royal Victoria Hospital Belfast
Belfast, Northern Ireland, BT12 6BA, United Kingdom
John Radcliffe Hospital
Oxford, Oxfordshire, OX3 9DU, United Kingdom
Freeman Hospital
Newcastle upon Tyne, Tyne and Wear, NE7 7DN, United Kingdom
Leeds General Infirmary
Leeds, West Yorkshire, LS1 3EX, United Kingdom
Queen Elizabeth Hospital (Edgbaston)
Birmingham, United Kingdom
The Heart Hospital
London, United Kingdom
Related Publications (1)
Pagel C, Utley M, Crowe S, Witter T, Anderson D, Samson R, McLean A, Banks V, Tsang V, Brown K. Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart. 2013 Oct;99(19):1445-50. doi: 10.1136/heartjnl-2013-303671. Epub 2013 Apr 5.
PMID: 23564473BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Rodney Franklin, MD
Royal Brompton & Harefield NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2014
First Posted
December 1, 2014
Study Start
April 1, 2000
Primary Completion
March 1, 2017
Study Completion
March 1, 2017
Last Updated
November 4, 2016
Record last verified: 2016-10